Oppenheimer Upgrades Emerson (EMR) to Outperform

March 21, 2014 6:23 AM EDT
Get Alerts EMR Hot Sheet
Price: $90.58 -0.69%

Rating Summary:
    17 Buy, 18 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 18 | New: 37
Trade Now! 
Join SI Premium – FREE
Oppenheimer upgraded Emerson (NYSE: EMR) from Perform to Outperform with a price target of $77.00.

Analyst Christopher Glynn comments, "We have regarded directional momentum of Network Power and Industrial Automation as linchpins for prospects for EMR shares to outperform, and view prospects for inflection now established. Process performance remains at a high level with steady and material drivers for sustainable growth. While smaller, Climate Technologies and C&R solutions also have visible market drivers and high-level margins, and, we think, improving market positioning. NP's and IA's strategic and cyclical positioning looks much improved, supporting prospects for multiple expansion and EPS upside over the next two years."

For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.

Shares of Emerson closed at $63.59 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Upgrades